- Other Post Graduate Training - University of California - Berkeley (2016-2018)
- Graduate School - University of California - Berkeley (2016-2018)
- Residency - Stanford University Medical Center (2014-2018), Radiation Oncology
- Internship - Presence Resurrection Medical Center (2013-2014), Transitional Year
- Medical School - University of Chicago Pritzker School of Medicine (2008-2013)
Kiran Kumar, M.D.
Chief of Lymphoma and Pediatrics Radiation Oncology Services; Program Director, Medical Residency
- Radiation Oncology
- Radiation Therapy for Lymphoma
- Radiation Therapy for Leukemia
New Patient Appointment Accepting Virtual Visits or 214-645-8525
Biography
Kiran Kumar, M.D., M.B.A., is an Associate Professor at UT Southwestern Medical Center and Chief of Lymphoma and Pediatrics Radiation Oncology Services. He specializes in the treatment of pediatric, lymphoma, and central nervous system cancers through the use of radiation therapies.
Dr. Kumar grew up in Arizona, where he earned dual undergraduate degrees in biochemistry and health administration at the University of Arizona. He then moved to Chicago, where he completed medical school at the University of Chicago Pritzker School of Medicine and a transitional year internship at Presence Resurrection Medical Center.
He followed that by completing his radiation oncology residency at Stanford University Medical Center, as well as graduate school at the University of California Berkeley-Haas School of Business, where he earned a degree in business administration.
Dr. Kumar went into medical school with a vague interest in oncology, based on prior experiences taking care of cancer patients as a hospice volunteer and doing research in a cancer pain laboratory, but he did not know much about radiation oncology until a shadowing experience as a first-year medical student.
“After just one week of shadowing, I knew radiation oncology was the perfect fit for me,” he says. “It combines my interest in technology and research with my passion for directly providing care for those dealing with one of the scariest diagnoses that exist – cancer.”
In addition to his clinical and research-related work, Dr. Kumar is passionate about medical and patient education, and consistently brainstorms innovative ways of improving patient education, such as audio and visual resources and support groups. He currently serves as Director of the Medical Residency Program.
Meet Dr. Kumar
Pediatric, lymphoma, and CNS cancer specialist in Dallas
Dr. Kumar focuses on treating patients with pediatric, lymphoma, and central nervous system cancers with radiation therapies. In general, he strives to provide the highest quality care using the most up-to-date techniques and therapies for all of his patients.
A strong believer in the importance of shared decision making, Dr. Kumar dedicates a significant amount of his time to patient education to ensure that his patients and their families have all the information they need to make an educated and informed decision regarding treatment. He wants his patients to know that while there are still risks with radiation treatment, it is often much less than they expect.
“Many people are afraid when they hear the word ‘radiation’, especially for children or young adults,” he says. “What most don’t realize is that radiation therapy has changed significantly over the last couple decades and with the latest technology and evidence from ongoing research, we are able to treat much more precisely and accurately with smaller volumes and less total dose, resulting in significantly fewer side effects.”
In addition to his clinical duties, Dr. Kumar is involved in a number of research projects, including SBRT for the treatment of spinal metastases, radiation therapy using PROMISE (pediatric radiation oncology with movie-induced sedation effect) technology to decrease the number of pediatric treatments requiring anesthesia, and the combination of immunotherapy with radiation therapy for treatment of primary or refractory/relapsed primary CNS lymphoma.
To Dr. Kumar, being a radiation oncologist is a privilege. Rather than just providing radiation treatments to patients, being there for all aspects of a patient’s life, both during and after treatment, is a highly rewarding experience.
“The most gratifying thing for me is seeing a child I took care of several years ago who has now gone off to college or gotten married and started a family of his or her own,” he says.
Education & Training
Professional Associations & Affiliations
- American Society for Radiation Oncology (ASTRO) (2013)
- American College of Radiation Oncology (ACRO) (2015)
- Radiological Society of North America (RSNA) (2014)
- American Society of Clinical Oncology (ASCO) (2019)
- Children’s Oncology Group (COG) (2019)
- International Society for Pediatric Oncology (SIOP) (2019)
- Pediatric Radiation Oncology Society (PROS) (2019)
- International Lymphoma Radiation Oncology Group (ILROG) (2018)
- The Radiosurgical Society (RRS) (2017)
Honors & Awards
- RSS Annual Scientific Meeting Award for Best Oral Presentation and Best Medical Resident Abstract 2017
- Stanford Honors Certificate in Medical Education 2017
- University of Chicago Department of Radiation Oncology Award 2013
- ASTRO Annual Meeting Scientific Abstract Award 2012
- Calvin Fentress Research Fellowship Award 2012
Books & Publications
-
Publications
-
Primary Stereotactic Body Radiotherapy for Spinal Bone Metastases From Lung Adenocarcinoma
Chou KN, Park DJ, Hori YS, Persad AR, Chuang C, Emrish SC, Ustrzynski L, Tayag A, Kumar K, Usoz M, Mendoza M, Rahimy E, Pollom E, Soltys SG, Lai SW, Chang SD Clinical lung cancer 2024 -
Serious Illness Communication Training Among Radiation Oncology Residents
Christensen M, Kumar KA, Wang WS, Dharmarajan KV, Chang Z, McStay CK, Barina A, Siropaides C Practical Radiation Oncology 2023 May 13 e220-e229 -
ACR–ARS Practice Parameter for the Performance of Total Body Irradiation
Reilly M, Dandapani SV, Kumar KA, Constine L, Fogh SE, Roberts KB, Small W, Schechter NR American Journal of Clinical Oncology: Cancer Clinical Trials 2023 May 46 185-192 -
Optimizing Palliative Focal Radiation Therapy Dose in Cutaneous T-Cell Lymphoma: How Low Can You Go?
Patel AM, West L, Atluri PS, Yi SF, Rizvi SM, Geethakumari PR, Awan FT, Chen W, Shah JL, Desai NB, Goff HW, Kumar KA Practical Radiation Oncology 2023 Mar 13 e192-e199 -
Artificial Intelligence–Empowered Radiation Oncology Residency Education
Kwon YS, Dohopolski M, Morgan H, Garant A, Sher D, Rahimi A, Sanford NN, Vo D, Albuquerque K, Kumar K, Timmerman R, Jiang SB Practical Radiation Oncology 2023 Jan 13 8-10 -
A Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma
Alsuwaidan A, Koduru P, Fuda F, Manuel Jaso J, Chen M, Rosado F, Luu HS, Sweed N, Garcia R, Doucet M, Desai NB, Kumar KA, Awan FT, Ramakrishnan Geethakumari P, Chen W American journal of clinical pathology 2022 Sep 158 338-344 -
Primary central nervous system lymphoma: A real-world comparison of therapy access and outcomes by hospital setting
Patel AM, Ali O, Kainthla R, Rizvi SM, Awan FT, Patel T, Pan E, Maher E, Desai NB, Timmerman R, Kumar KA, Ramakrishnan Geethakumari P Neuro-Oncology Practice 2022 May 9 183-192 -
T-Cell Lymphomas, Version 2.2022
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H JNCCN Journal of the National Comprehensive Cancer Network 2022 Mar 20 285-308 -
Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes
Zhang-Velten ER, Parsons D, Lee P, Chambers E, Abdulrahman R, Desai NB, Dan T, Wardak Z, Timmerman R, Vusirikala M, Patel PA, Simms-Waldrip T, Aquino V, Koh A, Tan J, Iqbal Z, Zhang Y, Reynolds Jr. RR, Chiu T, Joo M, Hrycushko B, Ouyang L, Lamphier R, Yan Y, Jiang SB, Kumar KA, Gu X Transplantation and Cellular Therapy 2022 Feb 28 113.e1-113.e8 -
Fundamentals of radiation oncology for treatment of vertebral metastases
Gottumukkala S, Srivastava U, Brocklehurst S, Mendel JT, Kumar K, Yu FF, Agarwal A, Shah BR, Vira S, Raj KM Radiographics 2021 Nov 41 2136-2156 -
Lymphomatoid granulomatosis of the central nervous system (CNS-LYG) posing a management challenge
Soleja M, Jaso JM, Chen W, Raisanen J, Wysocki CA, Shen YM, Mickey B, Kumar KA, Ramakrishnan Geethakumari P Clinical Case Reports 2021 Sep 9 -
Mulling the Modalities
Kumar KA, Timmerman RD International Journal of Radiation Oncology Biology Physics 2021 Aug 110 1266 -
Association Between Patient Education Videos and Knowledge of Radiation Treatment
Kumar KA, Balazy KE, Gutkin PM, Jacobson CE, Chen JJ, Karl JJ, von Eyben R, Horst KC International Journal of Radiation Oncology Biology Physics 2021 Apr 109 1165-1175 -
Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer
Westover KD, Travis Mendel J, Dan T, Kumar K, Gao A, Pulipparacharuv S, Iyengar P, Nedzi L, Hannan R, Anderson J, Choe KS, Jiang W, Abdulrahman R, Rahimi A, Folkert M, Laine A, Presley C, Munro Cullum C, Choy H, Ahn C, Timmerman R Neuro-oncology 2020 Dec 22 1831-1839 -
Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin
Sandhu N, Benson KR, Kumar KA, Eyben RV, Chang DT, Gibbs IC, Hancock SL, Meola A, Chang SD, Li G, Hayden-Gephart M, Soltys SG, Pollom EL Journal of Neurosurgery: Spine 2020 Jul 33 87-94 -
Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors
Chin AL, Fujimoto D, Kumar KA, Tupper L, Mansour S, Chang SD, Adler JR, Gibbs IC, Hancock SL, Dodd R, Li G, Gephart MH, Ratliff JK, Tse V, Usoz M, Sachdev S, Soltys SG Clinical Neurosurgery 2019 Nov 85 708-716 -
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non–Small-cell Lung Cancer
Chin AL, Kumar KA, Guo HH, Maxim PG, Wakelee H, Neal JW, Diehn M, Loo BW, Gensheimer MF Clinical lung cancer 2018 Sep 19 e581-e588 -
A Pilot Study Evaluating the Use of Dynamic Contrast-Enhanced Perfusion MRI to Predict Local Recurrence After Radiosurgery on Spinal Metastases
Kumar KA, Peck KK, Karimi S, Lis E, Holodny AI, Bilsky MH, Yamada Y Technology in Cancer Research and Treatment 2017 Dec 16 857-865 -
Cost-effectiveness of radiation and chemotherapy for high-risk low-grade glioma
Qian Y, Maruyama S, Kim H, Pollom EL, Kumar KA, Chin AL, Harris JP, Chang DT, Pitt A, Bendavid E, Owens DK, Durkee BY, Soltys SG Neuro-oncology 2017 Dec 19 1651-1660 -
Stereotactic Body Radiotherapy in the Treatment of Spinal Metastases
Katsoulakis E, Kumar K, Laufer I, Yamada Y Seminars in Radiation Oncology 2017 Jul 27 209-217 -
Radiation Therapy for Colorectal Liver Metastases
Qian Y, Kumar KA, Dudley SA, Koong AC, Chang DT Current Colorectal Cancer Reports 2017 Jun 13 240-249 -
Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR)Pre-treatment non-target lung FDG-PET uptake predicts radiation pneumonitis after SABR
Chaudhuri AA, Binkley MS, Rigdon J, Carter JN, Aggarwal S, Dudley SA, Qian Y, Kumar KA, Hara WY, Gensheimer M, Nair VS, Maxim PG, Shultz DB, Bush K, Trakul N, Le QT, Diehn M, Loo BW, Guo HH Radiotherapy and Oncology 2016 Jun 119 454-460 -
Image-guided radiation therapy for prostate cancer: A computed tomography-based assessment of fiducial marker migration between placement and 7 days
Kumar KA, Wu T, Tonlaar N, Stepaniak C, Yenice KM, Liauw SL Practical Radiation Oncology 2015 5 241-247 -
RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation
Widau RC, Parekh AD, Ranck MC, Golden DW, Kumar KA, Sood RF, Pitroda SP, Liao Z, Huang X, Darga TE, Xu D, Huang L, Andrade J, Roizman B, Weichselbaum RR, Khodarev NN Proceedings of the National Academy of Sciences of the United States of America 2014 Jan 111 E484-E491
-
Primary Stereotactic Body Radiotherapy for Spinal Bone Metastases From Lung Adenocarcinoma
Clinical Focus
- Radiation Therapy for Lymphoma
- Radiation Therapy for Leukemia
- Radiation Therapy for Brain Tumors
- Radiation Therapy for Spinal Cord Cancer
- Pediatric Brain Tumors
- Lymphoma Treatment
- Myeloma Treatment
- Bone Marrow Transplant
- Brain Metastases
- Brain & Spinal Cord Cancer
- Gliomas
- Meningiomas
- Skull Base Tumors
- Pituitary Tumors
- Acoustic Neuromas
- Sarcoma
- Cancerous (Malignant) Bone Tumors
- Skin Cancer
- Ocular Lymphoma
- Ocular oncology
Results: 1 Locations
University Hospital Radiation Oncology Clinic
at Radiation Oncology Building 2280 Inwood RoadDallas, Texas 75390 214-645-8525 Directions to University Hospital Radiation Oncology Clinic
New Patient Appointment Accepting Virtual Visits or 214-645-8525